PLoS By Category | Recent PLoS Articles

Hematology - Oncology

The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome
Published: Friday, August 31, 2012
Author: Sergio Matarraz et al.

by Sergio Matarraz, Cristina Teodosio, Carlos Fernandez, Manuel Albors, María Jara-Acevedo, Antonio López, María Gonzalez-Gonzalez, María Laura Gutierrez, Juan Flores-Montero, Carlos Cerveró, Marlies Pizarro-Perea, María Paz Garrastazul, Gonzalo Caballero, Oliver Gutierrez, Guy Daniel Mendez, Manuel González-Silva, Paula Laranjeira, Alberto Orfao

Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular dysplastic bone marrow (BM) associated with inefficient hematopoiesis and peripheral cytopenias due to increased apoptosis and maturation blockades. Currently, little is known about the role of cell proliferation in compensating for the BM failure syndrome and in determining patient outcome. Here, we analyzed the proliferation index (PI) of different compartments of BM hematopoietic cells in 106 MDS patients compared to both normal/reactive BM (n?=?94) and acute myeloid leukemia (AML; n?=?30 cases) using multiparameter flow cytometry. Our results show abnormally increased overall BM proliferation profiles in MDS which significantly differ between early/low-risk and advanced/high-risk cases. Early/low-risk patients showed increased proliferation of non-lymphoid CD34+ precursors, maturing neutrophils and nucleated red blood cells (NRBC), while the PI of these compartments of BM precursors progressively fell below normal values towards AML levels in advanced/high-risk MDS. Decreased proliferation of non-lymphoid CD34+ and NRBC precursors was significantly associated with adverse disease features, shorter overall survival (OS) and transformation to AML, both in the whole series and when low- and high-risk MDS patients were separately considered, the PI of NRBC emerging as the most powerful independent predictor for OS and progression to AML. In conclusion, assessment of the PI of NRBC, and potentially also of other compartments of BM precursors (e.g.: myeloid CD34+ HPC), could significantly contribute to a better management of MDS.